| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma
|
Zheng, Meng
|
|
|
69 |
11 |
p. 2345-2355
|
artikel
|
| 2 |
Augmenting engineered T-cell strategies in solid cancers through epigenetic priming
|
Nielsen, Aaraby Y.
|
|
|
69 |
11 |
p. 2169-2178
|
artikel
|
| 3 |
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer
|
Li, Mingjia
|
|
|
69 |
11 |
p. 2403-2408
|
artikel
|
| 4 |
CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment
|
Xin, Chao
|
|
|
69 |
11 |
p. 2333-2343
|
artikel
|
| 5 |
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells
|
Mousset, Charlotte M.
|
|
|
69 |
11 |
p. 2259-2273
|
artikel
|
| 6 |
Clinicopathological factors associated with tumor-infiltrating lymphocyte reactivity in breast cancer
|
Lee, Heejae
|
|
|
69 |
11 |
p. 2381-2391
|
artikel
|
| 7 |
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
|
Cortellini, Alessio
|
|
|
69 |
11 |
p. 2209-2221
|
artikel
|
| 8 |
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
|
Long, Qilai
|
|
|
69 |
11 |
p. 2305-2317
|
artikel
|
| 9 |
Differences in PD-1 expression on CD8+ T-cells in chronic myeloid leukemia patients according to disease phase and TKI medication
|
Lee, Min Young
|
|
|
69 |
11 |
p. 2223-2232
|
artikel
|
| 10 |
Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis
|
Varga, Zsófia
|
|
|
69 |
11 |
p. 2193-2207
|
artikel
|
| 11 |
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients
|
Daiko, H.
|
|
|
69 |
11 |
p. 2247-2257
|
artikel
|
| 12 |
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells
|
Ibrahim, Mohammed L.
|
|
|
69 |
11 |
p. 2233-2245
|
artikel
|
| 13 |
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma
|
Zheng, Yujia
|
|
|
69 |
11 |
p. 2371-2380
|
artikel
|
| 14 |
Immune resilience in response to cancer therapy
|
Gicobi, Joanina K.
|
|
|
69 |
11 |
p. 2165-2167
|
artikel
|
| 15 |
Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression
|
Wang, Jing-Jing
|
|
|
69 |
11 |
p. 2275-2289
|
artikel
|
| 16 |
Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
|
Sapski, Sabrina
|
|
|
69 |
11 |
p. 2291-2303
|
artikel
|
| 17 |
In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes
|
Nielsen, Morten
|
|
|
69 |
11 |
p. 2179-2191
|
artikel
|
| 18 |
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth
|
Umemura, Naoki
|
|
|
69 |
11 |
p. 2357-2369
|
artikel
|
| 19 |
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10
|
Michielon, Elisabetta
|
|
|
69 |
11 |
p. 2319-2331
|
artikel
|
| 20 |
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
|
Fröbom, Robin
|
|
|
69 |
11 |
p. 2393-2401
|
artikel
|
| 21 |
Silent acute appendicitis revealed by PET-CT during treatment with ipilimumab and nivolumab: a new immune-related adverse event
|
Mangas, C.
|
|
|
69 |
11 |
p. 2409-2410
|
artikel
|
Tijdschrift beschrijving